Pelthos Therapeutics PTHS
NYSE PTHS
$8.97 -0.40 (-4.27%)
As of: Nov 10, 2026 · 3:59 PM EST

Pelthos Therapeutics (PTHS) Total Non-Current Liabilities (2024 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Total Non-Current Liabilities of $105.52 million for Q2 2026, up 12.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Pelthos Therapeutics posted Total Non-Current Liabilities of $61.47 million.

  • By year, Total Non-Current Liabilities came in at $4.08 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $94.16 million (Q1 2026), $61.47 million (Q4 2025) and $42.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 102.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 117.60 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 33.91 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 96.04 Bn
10 Pelthos Therapeutics 32.83 Mn -55.57 Mn 11.99 Mn 105.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.52 Mn
Mar 31, 2026 94.16 Mn
Dec 31, 2025 61.47 Mn
Sep 30, 2025 42.01 Mn
Dec 31, 2024 4.08 Mn
API Access

Pelthos Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PTHS&period=max&api_key=YOUR_API_KEY